[Federal Register Volume 88, Number 171 (Wednesday, September 6, 2023)]
[Notices]
[Pages 60946-60947]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19134]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Lead Exposure and Prevention Advisory Committee

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Lead Exposure and Prevention 
Advisory Committee (LEPAC). This is a hybrid meeting which will occur 
in person and online and is open to the public. Advance registration by 
September 29, 2023, is needed to receive the information to attend the 
meeting. The registration link is provided in the addresses section 
below.

DATES: The meeting will be held on October 16, 2023, from 9 a.m. to 
4:30 p.m., EDT and October 17, 2023, from 9 a.m. to 1 p.m., EDT.

ADDRESSES: Register in advance at https://forms.office.com/pages/responsepage.aspx?id=eCgFR53Gc0uxesXQDXVJuPeyypfKOR5Gj2Gz6aPXBGpUREZISTBGVjczTFlLRU5NUjY0SFNaQTM0UC4u&web=1&wdLOR=c61C32E80-28BF-40D7-AC2D-E113AEFDAA23 to receive information to attend the meeting.

FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., M.P.H., 
Designated Federal Officer, National Center for Environmental Health, 
Centers for Disease Control and Prevention, 4770 Buford Highway, 
Atlanta, Georgia 30341, Telephone: 770-488-6774; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Background: The Lead Exposure and Prevention Advisory Committee was 
established under Section 2203 of Public Law 114-322, the Water 
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-21, 
Registry for Lead Exposure and Prevention Advisory Committee.
    Purpose: The LEPAC is charged with providing advice and guidance to 
the Secretary, Department of Health and Human Services (HHS), and the 
Director, CDC and Administrator, ATSDR, on (1) reviewing Federal 
programs and services available to individual communities exposed to 
lead; (2) reviewing current research on lead exposure to identify 
additional

[[Page 60947]]

research needs; (3) reviewing and identifying best practices, or the 
need for best practices regarding lead screening and the prevention of 
lead poisoning; (4) identifying effective services, including services 
relating to healthcare, education, and nutrition for individuals and 
communities affected by lead exposure and lead poisoning, including in 
consultation with, as appropriate, the lead exposure registry as 
established in section 2203(b) of Public Law 114-322; and (5) 
undertaking any other review or activities that the Secretary 
determines to be appropriate.
    Matters To Be Considered: The agenda will include presentations on 
the following topics: aligning HUD inspection protocols for assisted 
housing for the last 20 years, the environmental factors impacting lead 
reduction, EPA's proposal on lead dust clearance level and hazard 
standard, updates on blood lead testing instrument, lead related 
funding opportunities for community-based organizations, state policy 
actions related to the blood lead reference value, CDC's efforts to 
increase blood lead testing in children enrolled in Medicaid, and an 
update from the Preventing Lead Exposure in Adults workgroup. Agenda 
items are subject to change as priorities dictate.

Public Participation

    Oral Public Comment: The public comment period is scheduled on 
October 16, 2023, from 1:30 p.m. until 2 p.m., and October 17, 2023, 
from 9:15 a.m. until 9:45 a.m. EDT. Individuals wishing to make a 
comment during the public comment period, please email your name, 
organization, and phone number by October 1, 2023, to [email protected].
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-19134 Filed 9-5-23; 8:45 am]
BILLING CODE 4163-18-P